In relation to tumor stages, EGFR showed overexpression in stages 3 and 4 compared to normal samples, with statistically significant differences noted between stage 1 and stages 3–4, as well as between stage 2 and stage 4 (Figure 2b). The gene discussed is EGFR; the disease is neoplasm.